Agarperoxinols A and B: Two Unprecedented Tricyclic 6/6/7 Rearranged Humulene-Type Sesquiterpenoids That Attenuated the Neuroinflammation in LPS-Stimulated Microglial Models.
Chi Thanh MaSang Bin LeeIn Ho ChoJae Sik YuTianqi HuangTae Min LeeTu Loan LySung Won KwonJeong Hill ParkHyun Ok YangPublished in: ACS omega (2023)
Agarperoxinols A and B ( 1-2 ), two naturally occurring humulene-type sesquiterpenoids with an unprecedented tricyclic 6/6/7 ring, were discovered from the agarwood of Aquilaria malaccensis . Their structures were unambiguously determined by various spectroscopic data, experimental ECD calculations, and single-crystal X-ray diffraction analysis. Agarperoxinol B showed significant and dose-dependent neuroinflammatory inhibitory effects on various proinflammatory mediators, including NO, TNF-α, IL-6, and IL-1β, and suppressed iNOS and COX-2 enzymes in LPS-activated microglial cells. A mechanistic study demonstrated that agarperoxinol B remarkably inhibited the phosphorylation of the Akt and JNK signaling pathways. Agarperoxinol B also significantly reduced the expression of the microglial markers Iba-1, COX-2, and TNF-α in the mouse cerebral cortex. Our findings introduce a bioactive compound from natural products that decreases proinflammatory factor production and has application for the treatment of neurodegenerative diseases.
Keyphrases
- inflammatory response
- lipopolysaccharide induced
- lps induced
- signaling pathway
- induced apoptosis
- rheumatoid arthritis
- neuropathic pain
- high resolution
- pi k akt
- poor prognosis
- cell cycle arrest
- endoplasmic reticulum stress
- oxidative stress
- anti inflammatory
- cell death
- subarachnoid hemorrhage
- molecular docking
- electronic health record
- electron microscopy
- traumatic brain injury
- functional connectivity
- brain injury
- mass spectrometry
- big data
- spinal cord
- binding protein
- combination therapy
- computed tomography
- protein kinase
- cerebral ischemia
- long non coding rna